Treatment with N-acetyl cysteine (NAC) or ofloxacin (OFLO) as adjunct to IFN failed to achieve response in chronic hepatitis C patients non responding to IFN alone: A phase II study.

被引：0
|
作者：
Andreana, A [1 ]
Zampino, R [1 ]
Tonziello, A [1 ]
Adinolfi, LE [1 ]
Utili, R [1 ]
Ruggiero, G [1 ]
机构：
[1] UNIV NAPLES 2,INST MED THERAPY,NAPLES,ITALY
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 2 条
  • [1] Combination therapy with peginterferon α-2a (PEG-IFN) and ribavirin in the treatment of patients with chronic hepatitis C (CHC):: A phase II open-label study
    Sulkowski, M
    Reindollar, R
    Yu, J
    HEPATOLOGY, 1999, 30 (04) : 197A - 197A
  • [2] GI5005 IMMUNOTHERAPY PLUS PEG-IFN/RIBAVIRIN IN GENOTYPE I CHRONIC HEPATITIS C PATIENTS COMPARED TO PEG-IFN/RIBAVIRIN ALONE IN NAIVE AND NON-RESPONDER PATIENTS; PRELIMINARY RVR AND VIRAL KINETIC ANALYSIS FROM THE GI5005-02 PHASE 2 STUDY
    McHutchison, John G.
    Lawitz, Eric J.
    Vierling, John M.
    Everson, Gregory T.
    Jacobson, Ira M.
    Shiffman, Mitchell L.
    Boyer, Thomas D.
    Schiff, Eugene R.
    Cruickshank, Scott
    Rodell, Timothy C.
    Apelian, David
    HEPATOLOGY, 2008, 48 (04) : 1023A - 1024A
1